TCM Biotech International Corp. (TPEX:4169)
Taiwan · Delayed Price · Currency is TWD 173.00
+1.00 (0.58%)
Dec 31, 2025, 2:57 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 10.22 billion as of December 31, 2025. Its market cap has increased by 192.23% in one year.
Market Cap
10.22B
Enterprise Value
9.74B
Revenue
682.40M
Ranking
n/a
PE Ratio
484.65
Stock Price
173.00
Market Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 10.22B, an increase of 646.74%. That is a compound annual growth rate of 15.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 245.82B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 61.64B |
| Lin BioScience | 32.06B |
| Lumosa Therapeutics | 31.92B |
| Center Laboratories | 29.26B |